XOMA Corp (XOMA.OQ) Quote| Reuters.com
Edition:
United States

XOMA Corp (XOMA.OQ)

XOMA.OQ on NASDAQ Stock Exchange Global Market

0.52USD
24 Jun 2016
Change (% chg)

$-0.04 (-7.90%)
Prev Close
$0.57
Open
$0.53
Day's High
$0.55
Day's Low
$0.50
Volume
6,367,859
Avg. Vol
196,736
52-wk High
$4.92
52-wk Low
$0.50

XOMA.OQ

Chart for XOMA.OQ

About

XOMA Corporation is a development-stage biotechnology company. The Company focuses on the discovery and development of monoclonal antibody-based therapeutics. It has five products in its endocrine portfolio, two of which are developed as part of its XOMA Metabolism (XMet) platform. Its products include XOMA 358, XOMA 129, XOMA... (more)

Overall

Beta: 2.63
Market Cap(Mil.): $62.84
Shares Outstanding(Mil.): 120.37
Dividend: --
Yield (%): --

Financials

  XOMA.OQ Industry Sector
P/E (TTM): -- 38.82 34.11
EPS (TTM): -0.06 -- --
ROI: -17.31 -5.72 14.23
ROE: -- -4.83 15.46

BRIEF-Xoma Corp Q1 loss per share $0.07

* Xoma reports first quarter 2016 operational achievements and financial results

May 04 2016

BRIEF-Xoma initiates Xoma 358 proof-of-concept study in patients with Hypoglycemia post gastric bypass surgery

* Xoma initiates Xoma 358 proof-of-concept study in patients with Hypoglycemia post gastric bypass surgery Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)

Apr 27 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.